Wave life sciences to present at stifel 2022 cns days

Cambridge, mass., march 21, 2022 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate virtually in an analyst-led fireside chat at the stifel 2022 cns days event on monday, march 28, 2022, at 9:15 a.m. edt.
WVE Ratings Summary
WVE Quant Ranking